<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A man in his 30s with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> was admitted to our hospital with <z:hpo ids='HP_0001635'>heart failure</z:hpo> exacerbation </plain></SENT>
<SENT sid="1" pm="."><plain>Despite optimal medical treatment, his renal function progressively declined to <z:hpo ids='HP_0003774'>end-stage renal failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Type 2 cardiorenal syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRS</z:e>) was diagnosed and continuous ambulatory peritoneal dialysis was started </plain></SENT>
<SENT sid="3" pm="."><plain>He died of a <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> 4 years later </plain></SENT>
<SENT sid="4" pm="."><plain>Postmortem renal pathology revealed no significant changes in the glomeruli except for shrinkage, <z:mpath ids='MPATH_458'>normal</z:mpath> arterioles and focal degeneration of the tubules with peritubular <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>This suggests that renal replacement therapy can be withdrawn from some patients with type 2 CRS </plain></SENT>
</text></document>